These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38283643)

  • 1. Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease.
    Kandel A; Pant P; Todi S; Kc S; Pandey S
    SAGE Open Med; 2024; 12():20503121241227090. PubMed ID: 38283643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
    Federico A; Dallio M; Masarone M; Gravina AG; Di Sarno R; Tuccillo C; Cossiga V; Lama S; Stiuso P; Morisco F; Persico M; Loguercio C
    Oxid Med Cell Longev; 2019; 2019():8742075. PubMed ID: 31737175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?
    Montesi L; Caselli C; Centis E; Nuccitelli C; Moscatiello S; Suppini A; Marchesini G
    World J Gastroenterol; 2014 Aug; 20(29):10128-36. PubMed ID: 25110440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of berberine and bicyclol on Chinese patients with nonalcoholic fatty liver disease: a retrospective study.
    Geng Q; Zhang P; Liu X; Xue L
    Postgrad Med; 2022 Jun; 134(5):507-515. PubMed ID: 35382695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vegan Diet Advice Might Benefit Liver Enzymes in Nonalcoholic Fatty Liver Disease: an Open Observational Pilot Study.
    Chiarioni G; Popa SL; Dalbeni A; Senore C; Leucuta DC; Baroni L; Fantin A
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):81-87. PubMed ID: 33548123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of increased physical activity without body weight loss on hepatic inflammation in patients with nonalcoholic fatty liver disease.
    Asada F; Nomura T; Hosui A; Kubota M
    Environ Health Prev Med; 2020 Jun; 25(1):18. PubMed ID: 32522147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 9. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study.
    Lee YM; Low HC; Lim LG; Dan YY; Aung MO; Cheng CL; Wee A; Lim SG; Ho KY
    Gastrointest Endosc; 2012 Oct; 76(4):756-60. PubMed ID: 22840293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
    Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of thymol and vitamin E on nonalcoholic fatty liver disease in male Wistar rats.
    Lahmi A; Oryan S; Eidi A; Rohani AH
    Braz J Biol; 2023; 84():e268781. PubMed ID: 36629640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.
    Gutiérrez-Grobe Y; Chávez-Tapia N; Sánchez-Valle V; Gavilanes-Espinar JG; Ponciano-Rodríguez G; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2012; 11(3):350-5. PubMed ID: 22481454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research.
    Gottlieb A; Mosthael W; Sowa JP; Canbay A
    Digestion; 2019; 100(2):79-85. PubMed ID: 30537758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Hung CK; Bodenheimer HC
    Clin Liver Dis; 2018 Feb; 22(1):175-187. PubMed ID: 29128055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: diagnosis and management.
    Wilkins T; Tadkod A; Hepburn I; Schade RR
    Am Fam Physician; 2013 Jul; 88(1):35-42. PubMed ID: 23939604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between lifestyle factors and nutritional status and non-alcoholic fatty liver disease among a group of adult Jordanians.
    Tayyem RF; Al-Dayyat HM; Rayyan YM
    Arab J Gastroenterol; 2019 Mar; 20(1):44-49. PubMed ID: 30872135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dietary intervention and physical activity in children and adolescents with nonalcoholic fatty liver disease associated with obesity: A scoping review.
    Caro-Sabido EA; Larrosa-Haro A
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(2):185-194. PubMed ID: 31101468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.